What is Verility?
Verility is at the forefront of revolutionizing animal breeding and fertility management. Their flagship product, FERTILE-EYEZ, employs sophisticated image recognition and artificial intelligence to simplify critical reproductive assessments. This mobile-based solution streamlines sperm analysis and ovulation detection, offering a more accessible and efficient alternative to traditional methods. By enhancing the accuracy and ease of these analyses, Verility aims to significantly improve conception rates, thereby contributing to the robustness of the global food supply chain. The company's innovative approach addresses the inherent limitations of existing technologies, which are often characterized by high costs, time-intensive processes, and susceptibility to human error.
How much funding has Verility raised?
Verility has raised a total of $3.6M across 2 funding rounds:
Series A
$3.5M
Debt
$150K
Series A (2022): $3.5M with participation from Mountain Group Partners
Debt (2026): $150K, investors not publicly disclosed
Key Investors in Verility
Mountain Group Partners
Mountain Group Partners is a venture capital firm specializing in early-stage Life Sciences, AgTech, and Technology investments, known for its active role in shaping portfolio companies from inception.
What's next for Verility?
With its recent major strategic investment, Verility is poised for an accelerated growth trajectory. The company's focus on AI-driven solutions for animal fertility aligns with increasing demands for efficiency and precision in modern agriculture and animal husbandry. This capital is likely to be deployed towards further research and development, expanding the capabilities of their FERTILE-EYEZ system, and scaling their market reach. Strategic partnerships and broader adoption across the animal health industry are anticipated as Verility solidifies its position as a leader in fertility technology.
See full Verility company page
